Abstract
Through interacting with BDNF, vascular endothelial growth factor (VEGF) has been implicated in the antidepressant action of ketamine. VEGF is also linked to pigment epithelial-derived factor (PEDF), which inhibits VEGF and is neurotrophic. Plasma PEDF is increased in depressed patients and further increased post-ECT. We therefore explored the effect of single ketamine infusions on peripheral blood mRNA levels of VEGFA and PEDF (SERPINF1) and their relationship in patients with depression.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
